Highline Wealth Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
LMFP
AAMU
CRM
SP
ORIO
CNB
Highline Wealth Partners's MRK Position: Q2 2026 in Review
Highline Wealth Partners reduced its Merck (MRK) stake by 2.3% in Q2 2026, selling an estimated $2.58K and leaving 932 shares worth $120K. The position accounts for 0.02% of the portfolio, ranked #151.
Highline Wealth Partners first reported a position in MRK in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.34M in Q1 2024. 810 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Highline Wealth Partners held 932 shares of Merck worth $120K as of Q2 2026.
- Highline Wealth Partners sold 22 Merck shares in Q2 2026, an estimated $2.58K.
- Merck made up 0.02% of Highline Wealth Partners's portfolio in Q2 2026, its #151 holding.
- Highline Wealth Partners first reported a position in Merck in Q3 2022 and has held it in 16 quarters since.
- Highline Wealth Partners's Merck position peaked at $1.34M in Q1 2024.
- 810 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.